ANGELICA CASTILLO REYES
Prescription History 1306382213
Nurse Practitioner - Family in Las Vegas, NV

Active since January 17, 2017PECOS EnrolledAccepts Medicare Assignment
3201 S MARYLAND PKWY STE 218, LAS VEGAS, NV 89109(702) 862-8075(702) 862-8077 Get Directions

NPPES record last updated: June 30, 2026. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Record update history: Jun 2, 2026, Nov 19, 2024, May 6, 2024 and 4 more (7 updates tracked since 2017).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ANGELICA CASTILLO REYES, an active Family specialist practicing in Las Vegas, NV. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 25 documented patient claims. Among these therapy options, the most frequently utilized medication is Descovy, which accounts for 25 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
25
Total Claims
29
30-Day Fills
Descovy
Most Prescribed · 25 claims
View details
1 medication · 2024 Medicare Part D
Medicare Part D medications prescribed by ANGELICA CASTILLO REYES in 2024, with prescription volumes, average cost per fill, and NV state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other NV PrescribersVs. NV Avg
DescovyEmtricitabine/Tenofov Alafenam25$2,524.42≈ Typical

About Descovy: This product is used with other HIV medications to help control HIV infection. Show more ▾

It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of two different drugs: emtricitabine and tenofovir alafenamide. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor. They are often called NRTIs. This product should not be used by itself to help control HIV infection. Doing so can make your treatment less effective. Use combination treatment with at least one other HIV medication. This product is also approved in the US to help prevent HIV infection in people who have a high risk for infection. Some things that increase risk include having a partner infected with HIV, having unprotected sex, having multiple sex partners, infection with a sexually transmitted disease-STD, or use/abuse of drugs or alcohol. Emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.

In 2024, this provider wrote 25 Medicare prescriptions for Descovy, about 75% of the volume of the typical Nevada prescriber of this medication (33.2). Medicare paid an average of $2,524.42 per fill, versus $2,278.28 statewide.

How often this provider prescribes it

This provider
25
NV average
33.2

This provider's prescribing volume for this medication is in line with the average NV prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$2,524.42
NV average
$2,278.28

Gross Part D cost per fill; not the patient's out-of-pocket price.

29
30-Day Fills
standardized to 30-day supplies
870
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average NV prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the NV average cost per fill.

About this data. The prescription history for ANGELICA CASTILLO REYES is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Family prescribing approach at this Las Vegas, NV practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among NV prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.